期刊文献+

肝细胞癌中胰岛素样生长因子1受体及血管内皮生长因子的表达及意义 被引量:3

Significance of insulin-like growth factor 1 receptor and vascular endothelial growth factor expression in hepatocellular carcinoma
下载PDF
导出
摘要 目的探讨胰岛素样生长因子1受体(IGF-1R)和血管内皮生长因子(VEGF)在肝细胞癌(HCC)中的表达与HCC临床病理特征之间的关系及在HCC预后评估中的意义。方法采用免疫组织化学EnVision两步法检测石蜡包埋HCC病例癌组织及配对癌旁组织中IGF-1R及VEGF的蛋白表达,并计数微血管密度(MVD),结合临床病理特征和随访结果进行分析。结果 (1)IGF-1R、VEGF的蛋白表达水平及MVD计数在癌组织高于癌旁组织(P<0.05);(2)IGF-1R及VEGF的蛋白表达在不同病理分级、TNM分期、有无血管浸润及预后组间比较差异均有统计学意义(P<0.05)。(3)IGF-1R及VEGF的蛋白表达强度与MVD水平、IGF-1R的蛋白表达强度与VEGF的蛋白表达强度间均呈正相关。结论IGF-1R及VEGF促进了HCC的发生和发展且与预后密切相关,可用于其预后评估。 Objective To investigate the expression of insulin‐like growth factor 1 receptor (IGF‐1R) ,vascular endothelial growth factor (VEGF) and their relationships between clinic opathologic features in hepatocellular carci‐noma (HCC) .Method Immunohistochemical envision method was utilized to detect the expression of IGF‐1R and VEGF ,MVD was counted .The follow‐up data of the cases of HCC was analyzed .Result The IGF‐1R and VEGF protein shown a higher expression in HCC than in the tumor‐adjacent tissues (P〈 0 .05) .The difference of the number of IGF‐1R and VEGF protein overexpression in histological grade and TNM stage and prognosis was signifi‐cant (P〈0 .05) ,moreover ,the vascular infiltration group was significantly more than group without vascular inva‐sion (P〈0 .05) .The value of MVD was higher in HCC than that in tumor‐adjacent tissues .By Spearman rank cor‐relation analysis ,the level of MVD was positively correlated with IGF‐1R protein expression and VEGF protein ex‐pression .Moreover ,the expression of IGF‐1R and VEGF protein was also positive correlation .Conclusion IGF‐1R and VEGF protein may promote the occurrence and development of HCC ,and they all promote the neovasculation in HCC .The expression of IGF‐1R and VEGF can be used as a marker to evaluate the prognosis of HCC .
出处 《贵州医药》 CAS 2015年第9期776-778,共3页 Guizhou Medical Journal
基金 贵州省科学技术基金项目[黔科合J字KLG(2013)27号] 贵州省科学技术基金项目[黔科合J字(2009)2187号] 贵州省科技计划项目[黔科合SY字(2011)3062号] 贵阳市科学技术计划项目[(2009)筑科农合同字第3-020号]
关键词 肝细胞癌 胰岛素样生长因子1受体 血管内皮生长因子 免疫组织化学 预后 Hepatocellular carcinoma Insulin-like grow th factor 1 receptor Vascular endothelial grow th factor Immunohistochemistry Prognosis
  • 相关文献

参考文献10

  • 1Jemal A,Bray F,Center MM,et al . Global cancer sta tisties[J]. CA Cancer J Clin,2011,61 (2) :69 90.
  • 2Tsuta K, Mimae T, Nitta H, et al. Insulin like growth factor 1 receptor protein expression and gene copy number alterations in non small cell lung carcinomas J. Hum Pathol,2013,44(6):975-982.
  • 3万健,唐才喜,冯斌,陈迅,王志明.原发性肝癌中Numb和VEGF的表达及临床意义[J].中国普通外科杂志,2015,24(1):39-44. 被引量:21
  • 4Wang WQ, Liu L, Xu HX, et al. The combination of HTATIP 2 expression and microvessel density predicts converse survival of hepatocellular carcinoma with or with out sorafenibJ. Oncotarget, 2014 ( 11 ) .. 3895-3906.
  • 5Yao WF,Liu JW,Sheng GI.,et al. Blockade of IGF 1R exerts anticancer ef{ects in hepatocellular carcinoma [J]. Mol Med Rep,2011,4(4)719 722.
  • 6成莉邢辉.宫颈癌IGF—IR的表达及与肿瘤血管生成、癌细胞增殖关系[J].浙江临床医学,2013,15(10):1461-1463. 被引量:9
  • 7Christopoulos PF, Msaouel P, Koutsilieris M. The role of the insulin-like growth factor-1 system in breast cancer[J]. Mol Cancer,2015,14(1) :43-43.
  • 8Yang Z,Wang YG,Su K. VEGF-C and VEGF-D ex pression and its correlation with lymph node metastasis in esophageal squamous cell cancer tissue [J]. Asian Pac J Cancer Prev,2015,16(1) :221-274.
  • 9Desbois-Mouthon C,Baron A,Blive>Van Eggelpoel MJ, et al. Insulin-like growth factorq receptor inhibition induces a resistance mechanism via the epidermal growth factor re- ceptor/HER3/AKT signaling pathway: rational basis for targeting insulin-like growth factol receptor and epider- mal growth factor receptor in hepatocellular carcinoma[J]. Clin Cancer Res, 2009,15 (17) : 5445-5456.
  • 10王进,曾祥,胡伟民.IGF-1R、EGFR、VEGF、HER2在胃癌组织中的表达及与其预后的关系[J].实用癌症杂志,2012,27(5):468-471. 被引量:21

二级参考文献27

  • 1Melchiorre Cervello,Giuseppe Montalto.Cyclooxygenases in hepatocellular carcinoma[J].World Journal of Gastroenterology,2006,12(32):5113-5121. 被引量:25
  • 2林春艳,曹海燕,辛丽亚.血清中VEGF与AFP联合检测在原发性肝癌辅助诊断中的研究[J].哈尔滨医科大学学报,2006,40(6):483-485. 被引量:4
  • 3Parki DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global Picture[J]. Eur J Caneer,2001,37 :54.
  • 4Crew KD, Neugut A1. Epidemiology of gastric cancer[J]. World J Gastroenterol,2006,12:354.
  • 5Ciardiello F, Tortora G. EGFR antagonists in cancer treat- ment[J]. N Engl J Med,2008,358( 11 ) :1160.
  • 6Molinari F, Martin V, Saletti P, et al. Differing deregulation of EGFR and downstream proteins in primary colorectal cancer and related metastatic sites may be clinically relevant[J]. Br J Cancer,2009,100(7) : 1087.
  • 7Pollak MN, Schernhammer ES, Hankinson SE. Insulin-like g- rowth factors and neplasia[J]. NAT Rev Cancer, 2004,4 : 505.
  • 8Carboni JM, Lee AV, Hadsell DL, et al. Tumor development by transgenic espression of constitutively active insulin-like growth factor 1 receptor[J]. Cancer Res, 2005,65 ( 9 ) : 3781.
  • 9Matsubara J,Yamada Y, Hirashima Y, et al. Hnpact of insu- lin-Like growth factor type-1 receptor, epidermal growth fac- tor recaptor,and HER2 expressions on outcomes of patientswith gastric cancer[J].Clin Cancer Res, 2008, 14 (10) : 3022.
  • 10James R, Tonra. Prioritiation of EGFR/IGF-1R/VEGFR2 c- ombination targed therapies utilizing cancer models [J]. An- tieancer Research ,2009,29 : 1999.

共引文献48

同被引文献68

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部